Dopaminergic Loss and Pain in Parkinson's Disease
NCT00940914
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Parkinson's Disease
Pain
Interventions
DRUG:
ioflupane 123I (DATSCAN®)
Sponsor
University Hospital, Toulouse